Pediatric Neuro-Oncology

Posting Summary

Rutgers Cancer Institute of New Jersey, the state’s only NCI-designated Comprehensive Cancer Center, located in New Brunswick, NJ, is seeking a Pediatric Neuro-Oncologist to join the Division of Pediatric Hematology/Oncology.

This position offers a unique opportunity to work closely with diverse pediatric specialties such as pediatric neurosurgery and pediatric neuroradiology at a well-established practice site with a robust support staff. The ideal candidate has the opportunity to contribute to ongoing trial accrual and to develop independent research and teaching initiatives with medical students, fellows, and house staff.

Applicants with interests in building a busy clinical practice and/or clinical research programs are also encouraged to apply. Attractive clinical research support packages exist for qualified candidates.

Academic appointment (Assistant Professor-Professor) will be commensurate with experience and housed in the Rutgers Robert Wood Johnson Medical School with a resident faculty appointment at the Rutgers Cancer Institute of New Jersey. Faculty at the Rutgers Robert Wood Johnson Medical School will have the opportunity to engage in exciting teaching and mentorship activities for junior faculty and graduate students.
Division of Pediatric Hematology and Oncology

The multidisciplinary team of experts within the Division of Pediatric Hematology and Oncology combines exceptional expertise, knowledge, and skill with advanced therapies to treat benign and malignant conditions in children, adolescents and young adults in a comprehensive and compassionate environment. Physicians are among the nation’s most experienced with expertise in routine, rare and complex cancers and blood disorders. Our clinical researchers lead innovative trials, with active roles in cooperative groups, as well as industry-sponsored and investigator-initiated trials.

The Pediatric Cancer and Blood Disorder Research Program is a newly-formed Center of Excellence at the Rutgers Cancer Institute, created in 2021 and supported by a dedicated appropriation from the State of New Jersey. The broad objectives of this Program are to support laboratory science focused on the biology of pediatric cancer and blood disorders as well as translational and clinical research focused on improving therapeutic options for children diagnosed with these conditions.

Rutgers Cancer Institute of New Jersey, the state’s only NCI-designated Comprehensive Cancer Center located in New Brunswick, NJ, and RWJBarnabas Health, the state’s largest health care delivery system, partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials. Visit .

Faculty will have the exciting opportunity to be involved in teaching activities for medical students and residents as well as targeted lectures in their area of expertise.

For questions on this position or to learn more about our available positions , please contact the Rutgers Cancer Institute Faculty Recruitment Office at .

Position Status Full Time Posting Number 22FA1504 Posting Open Date 08/01/2023 Posting Close Date Qualifications Minimum Education and Experience MD/DO Board Certification in Pediatrics, Pediatric Hem/Onc Fellowship training in neuro-oncology Clinical expertise in neuro-oncology NJ license or eligible for NJ licensure Certifications/Licenses Required Knowledge, Skills, and Abilities Equipment Utilized Physical Demands and Work Environment Overview RBHS New Jersey’s premier academic health center, Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care, and conducting research, all with the goal of improving human health. Aligned with Rutgers University–New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes that focus on cancer treatment and research, neuroscience, advanced biotechnology and medicine, environmental and occupational health, and health care policy and aging research. Our renowned faculty are teachers, health researchers and providers, and scientists with unparalleled experience who advance medical innovation and provide patient care informed by the latest research findings. We offer an outstanding education and training in medicine, dentistry, pharmacy, public health, nursing, biomedical research, and the full spectrum of allied health careers. An important mission of RBHS is to promote the careers of faculty, staff, and learners. Through this community of healers, scientists, and scholars, Rutgers is equipped as never before to transform lives.

Rutgers Robert Wood Johnson Medical School
As one of the nation’s comprehensive medical schools, Rutgers Robert Wood Johnson Medical School (RWJMS) is dedicated to pursuing excellence in education, research, healthcare delivery, and the promotion of community health. In cooperation with Robert Wood Johnson University Hospital, the medical school’s principal affiliate, they comprise New Jersey’s premier academic medical center. In addition, RWJMS has 34 other hospital affiliates and ambulatory care sites throughout the region. RWJMS encompasses 20 basic science and clinical departments and hosts centers and institutes, described below. The medical school maintains undergraduate, graduate, and postgraduate educational programs for more than 1,500 students on its campuses in New Brunswick and Piscataway. It provides continuing education courses for healthcare professionals and community education programs. Previously an academic unit of the University of Medicine and Dentistry of New Jersey, RWJMS became part of Rutgers, The State University of New Jersey, as part of the New Jersey Medical and Health Sciences Education Restructuring Act, on July 1, 2013.
Rutgers Cancer Institute As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, is a leader in cancer research, treatment, prevention, and education. Rutgers Cancer Institute offers world-class cancer care, providing patients with the most advanced treatment options through an integrated cancer care network, including clinical trials, immunotherapy, precision medicine, complex surgical procedures, and sophisticated radiation therapy techniques. Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, are one of only two programs in the state to offer blood and marrow transplantations and CAR T-cell therapy. It also houses the state’s only hospital-based proton therapy center. Rutgers Cancer Institute is a cornerstone of New Jersey’s premier academic health center, Rutgers Biomedical and Health Sciences (RBHS).

Construction is currently underway for a new $750 million state-of-the-art Cancer Center adjacent to the current Rutgers Cancer Institute facility and Robert Wood Johnson University Hospital. The 510,000 square foot Jack and Sheryl Morris Cancer Center will be the state’s first free-standing cancer hospital. It will feature outpatient and inpatient clinical space—including 84 infusion bays, 74 exam rooms, and 96 inpatient beds. This is in addition to state-of-the-art laboratories where critical scientific investigation will be amplified, enabling physician-scientists to translate findings directly to patients. The Jack and Sheryl Morris Cancer Center will also have the capacity to offer wellness and education resources all in one location. Learn more about this incredible facility at .

Rutgers Cancer Institute is home to nearly 250 internationally recognized physicians and researchers. The long-standing relationship with their NCI Research Consortium Partner Princeton University was recently leveraged to establish the Ludwig Cancer Research Princeton Branch with several faculty as founding members and leaders of the Branch. Their work on cancer metabolism, not only through the new Ludwig Branch but also through the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute, will accelerate and translate laboratory discoveries into clinical treatments through more effective and efficiently designed clinical trials.

The Rutgers Cancer Institute’s Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence is an institute at the intersection of oncologic immunology and metabolism that seeks to increase research that leads to new therapies for patients; develop cutting-edge facilities to test new interventions; and facilitate commercial and university collaborations. This includes discovery and production of novel cell therapy constructs via an institutional good manufactory practices (GMP) facility. Visit .

Rutgers Cancer Institute is committed to retaining, recruiting, and developing outstanding faculty, staff, and students, including those traditionally underrepresented in medicine in faculty, staff, and student bodies. It aspires to be an agent of progress in advancing equality and justice while improving healthcare access and reducing healthcare disparities. Visit us .More information on our community . Statement Rutgers Cancer Institute of New Jersey , the state’s only NCI-designated Comprehensive Cancer Center and RWJBarnabas Health, the state’s largest health care delivery system partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Through the above mentioned partnership and an academic appointment at Rutgers, The State University of New Jersey, unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials.

Mission
To accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer prevention; to provide outstanding, novel, and compassionate patient care; to provide evidence-based and culturally informed education to physicians, nurses, researchers, staff, and the community; and to achieve cancer health equity in our state through outreach to and engagement of our extraordinarily diverse communities

Vision
Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused research worldwide and reduce the burden of cancer in our catchment area. By engaging with and empowering our exceptionally diverse populations, and addressing their questions and fears, we will engender hope for cancer patients and their families and play a critical role in strengthening the fabric of our communities by gaining and protecting their trust and providing access to the outstanding oncology care each person deserves.

Core Values
• Curiosity and Discovery : encouraging an environment of continuous inquiry, creativity, and innovation to generate new knowledge
• Integrity : earning the trust of those we serve and each other through honesty, transparency, accountability, and continuous reflection
• Collaboration : approaching all opportunities with an understanding that together we are better and can achieve more; promoting and maintaining an environment of teamwork and shared knowledge
• Cultivating Diversity : making conscientious efforts in all we do to ensure that our leadership, scientists, clinicians, supporting staff, and trainees reflect the rich diversity of the state of New Jersey and the patient populations and communities we serve
• Respect and Caring : consistently demonstrating caring, compassion, and respect through our words and actions
• Perseverance : maintaining an unwavering commitment to our mission; embracing change, overcoming obstacles, and creating and recreating the path to achieve our goals

Rutgers Cancer Institute Commitment to Diversity, Equity, and Inclusion It is our responsibility to every participant in the healthcare space to address the longstanding, systemic structures of racism that affect our faculty and staff from thriving in the advancement of science and patient care. We understand that our patients, faculty, and staff come from all over and carry unique cultures and norms that impact how they interpret the world, their experiences, and their relationships. We are committed to fostering a diverse and inclusive environment where people who seek cancer care and the workforce that provide cancer care, both directly and indirectly, feel represented, welcomed, included, and supported.

---